Institutional investors purchased a net $3.4 million shares of SGMO during the quarter ended March 2015 and now own 76.64% of the total shares outstanding. This majority interest is a greater percentage than is typical for companies in the Biotechnology industry and highlights that the smart money sees this stock as an important holding.
Mutual fund holders
Largest Quarterly Institutional Transactions
Latest Institutional Activity
INVESCO POWERSHARES CAPITAL MANA... Bought 858.1 Thousand shares of Sangamo BioSciences Inc
DEUTSCHE BANK SECURITIES, INC. Bought 480.2 Thousand shares of Sangamo BioSciences Inc